📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Recent UK type 2 diabetes treatment guidance represents a near whole population indication for SGLT2-inhibitor therapy (2023)

First Author: Young K

Attributed to: MICA: MRC APBI STratification and Extreme Response Mechanism IN Diabetes - MASTERMIND funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1101/2023.08.04.23293666

Publication URI: http://dx.doi.org/10.1101/2023.08.04.23293666

Type: Preprint